ABS — Arctic Bioscience AS Share News
0.000.00%
Last trade - 00:00- NOK88.96m
- NOK149.14m
- NOK40.10m
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -6.5 Million
Norway's Arctic Bioscience 2025 revenue falls due to product recall impact
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -7.8 Million
Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million
Brief: Arctic Bioscience Says 12-Month Data Confirm Potential For Hro350 In Mild-To-Moderate Psoriasis
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -9.1 Million
Brief: Arctic Bioscience: Encouraging Top-Line Results From The Heropa Clinical Study
Brief: Arctic Bioscience Partners With Kotler To Develop China, Other SE Asian Markets
Corrected: BRIEF-Arctic Bioscience Q3 Adjusted EBITDA NOK -8.4 Million
Brief: Arctic Bioscience Says It Has Liquidity Giving Runway Into Q1
Corrected: BRIEF-Arctic Bioscience Q3 Adjusted EBITDA NOK -8.4 Million
Brief: Arctic Bioscience Announces top-line results from the phase 2b HeROPA study
Brief: Arctic Bioscience Says New Cellular Research Showing Anti-Psoriatic Effects
Brief: Arctic Bioscience H1 Adjusted EBITDA Loss Widens To NOK 20.9 Mln
Brief: Arctic Bioscience Q1 Adjusted EBITDA Loss Widens To NOK 12.7 Mln
Brief: Arctic Bioscience: Positive Order Backlog For 2024 For Nutraceutical Business
Brief: Arctic Bioscience Q4 Adjusted EBITDA NOK -9.9 Million
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -10.4 Million
Brief: Arctic Bioscience Aims For Total Year Over Year Revenue Growth In 2023 Of 30-35 %